The invention relates to pharmaceutical combination preparations containing erythropoietin and one or several modified haemoglobins. The inventive combination preparations are used especially for treating manifest anaemia. The inventive pharmaceutical combination preparation comprises a) individual forms of administration of an erythropoietin preparation suitable for an individual dose of a quantity of 3,000 - 7,000 U of the active agent and b) 50 - 100 ml of one or several modified haemoglobins. The erythropoietin preparation and the modified haemoglobin can be provided in separate or single forms of administration.
